DCA works by inhibiting PDK, which in turn activates the enzyme pyruvate dehydrogenase (PDH). This activation shifts cellular metabolism from glycolysis (anaerobic) to glucose oxidation (aerobic), promoting a more normal metabolic state in cancer cells. This switch in metabolism can make cancer cells more susceptible to apoptosis (programmed cell death) and less capable of rapid growth and proliferation.
